Staid Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -18.98%
- Profit Growth -16.28%
- Ebitda 90.96%
- Net Worth 24.02%
- Total Assets 9.33%
About Staid Lifesciences
Staid Lifesciences Private Limited (SLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 01 February 2018 (Seven years 15 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Electrnoics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dhruv Dawar and Vijay Dawar serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U52609DL2018PTC329042
-
Company No.
329042
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Feb 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Staid Lifesciences Private Limited offer?
Staid Lifesciences Private Limited offers a wide range of products and services, including Sexual Wellness Products, Female Hygiene Products & Test Kits, Medical Laboratory Instruments, Rapid Test Kit.
Who are the key members and board of directors at Staid Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhruv Dawar
|
Director | 01-Feb-2018 | Current |
|
Vijay Dawar
|
Director | 01-Feb-2018 | Current |
Financial Performance of Staid Lifesciences.
Staid Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 18.98% decrease. The company also saw a substantial fall in profitability, with a 16.28% decrease in profit. The company's net worth Soared by an impressive increase of 24.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Staid Lifesciences?
Unlock access to Staid Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Staid Lifesciences?
Unlock and access historical data on people associated with Staid Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Staid Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Staid Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.